CoChat

Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson’s disease

Open access
Locascio, Joseph J., Eberly, Shirley, Liao, Zhixiang, Liu, Ganqiang, Hoesing, Ashley N., Duong, Karen, Trisini-Lipsanopoulos, Ana, Dhima, Kaltra, Hung, Albert Y., Flaherty, Alice W., Schwarzschild, Michael A., Hayes, Michael T., Wills, Anne-Marie, Shivraj Sohur, U., Mejia, Nicte I., Selkoe, Dennis J., Oakes, David, Shoulson, Ira, Dong, Xianjun, Marek, Ken, Zheng, Bin, Ivinson, Adrian, Hyman, Bradley T., Growdon, John H., Sudarsky, Lewis R., Schlossmacher, Michael G., Ravina, Bernard, Scherzer, Clemens R. · 2015 · Brain
Cited by 91

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

There are no cures for neurodegenerative diseases and this is partially due to the difficulty of monitoring pathogenic molecules in patients during life. The Parkinson’s disease gene α-synuclein (SNCA) is selectively expressed in blood cells and neurons. Here we show that SNCA transcripts in circulating blood cells are paradoxically reduced in early stage, untreated and dopamine transporter neuroimaging-supported Parkinson’s disease in three independent regional, national, and international populations representing 500 cases and 363 controls and on three analogue and digital platforms with P < 0.0001 in meta-analysis. Individuals with SNCA transcripts in the lowest quartile of counts had an odds ratio for Parkinson’s disease of 2.45 compared to individuals in the highest quartile. Disease-relevant transcript isoforms were low even near disease onset. Importantly, low SNCA transcript abundance predicted cognitive decline in patients with Parkinson’s disease during up to 5 years of longitudinal follow-up. This study reveals a consistent association of reduced SNCA transcripts in accessible peripheral blood and early-stage Parkinson’s disease in 863 participants and suggests a clinical role as potential predictor of cognitive decline. Moreover, the three independent biobank cohorts provide a generally useful platform for rapidly validating any biological marker of this common disease. The α-synuclein gene, SNCA, is selectively expressed in blood cells and neurons. Locascio et al. reveal a paradoxical reduction in SNCA transcript counts in the blood of individuals with early-stage, neuroimaging-supported Parkinson’s disease in three regional, national, and international populations. Low SCNA transcript abundance predicted subsequent cognitive decline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awv202

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 91

Metadata

Authors
Locascio, J. J., Eberly, S., Liao, Z., Liu, G., Hoesing, A. N., Duong, K., Trisini-Lipsanopoulos, A., Dhima, K., Hung, A. Y., Flaherty, A. W., Schwarzschild, M. A., Hayes, M. T., Wills, A.-M., Shivraj Sohur, U., Mejia, N. I., Selkoe, D. J., Oakes, D., Shoulson, I., Dong, X., Marek, K., Zheng, B., Ivinson, A., Hyman, B. T., Growdon, J. H., Sudarsky, L. R., Schlossmacher, M. G., Ravina, B., & Scherzer, C. R.
Venue
Brain
Published
2015-07-28
Volume
138
Issue
9
Pages
2659-2671
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W1905907413
Cited by
91
References
6
FWCI
4.66
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson’s disease. https://app.cochat.ai/papers/10.1093/brain/awv202
The paper
Locascio, J. J., Eberly, S., Liao, Z., Liu, G., Hoesing, A. N., Duong, K., Trisini-Lipsanopoulos, A., Dhima, K., Hung, A. Y., Flaherty, A. W., Schwarzschild, M. A., Hayes, M. T., Wills, A.-M., Shivraj Sohur, U., Mejia, N. I., Selkoe, D. J., Oakes, D., Shoulson, I., Dong, X., . . . Scherzer, C. R. (2015). Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson’s disease. Brain. https://doi.org/10.1093/brain/awv202

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.